This is an opinion item.
| Author(s)
|
The New York Times editorial board
|
| Source
|
The New York Times
|
| Date
|
April 5, 2010
|
| URL
|
http://www.nytimes.com/2010/04/06/opinion/06tue1.html
|
| Quote
|
|
"The unanswered question is whether — as the critics charge — the change will push a lot of employers into dropping their retiree drug plans. The remaining tax subsidy is substantial and many companies and their workers value the retiree drug benefit, so defections may be small. If some retirees do lose their company drug benefits, they can buy government-subsidized coverage in Medicare that may be just or almost as good and will be getting better as health care reform progresses."
|
|
|
Add or change this opinion item's references
This item argues against the position Act should not have been passed on the topic Patient Protection and Affordable Care Act.
